Company: SUPN
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001356576-25-000071
Chunk: 138

Company: SUPERNUS PHARMACEUTICALS, INC.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part I, Item 1
Chunk 138
---
 2025, H.R.1, also referred to as the One Big Beautiful Bill Act (OBBBA), was signed into law in the U.S. The OBBBA includes changes to U.S. federal tax law, including extending and modifying certain key Tax Cuts and Jobs Act of 2017 provisions, and provisions allowing accelerated tax deductions for qualified property and research expenditures. The Company is currently planning to continue recovering the unamortized balance of research and development expenditures as of December 31, 2024, over the original five and fifteen year period, and will begin currently expensing research and development in 2025.

13.    Leases

Operating lease assets and lease liabilities as reported on the condensed consolidated balance sheets are as follows (dollars in thousands):Balance Sheet ClassificationSeptember 30, 2025December 31, 2024(unaudited)AssetsOperating lease assetsOther assets$28,761 $24,477 Total lease assets$28,761 $24,477 LiabilitiesOperating lease liabilities, current portionAccounts payable and accrued liabilities$10,790 $6,889 Operating lease liabilities, long-termOperating lease liabilities, long-term31,422 27,382 Total lease liabilities$42,212 $34,271 

29

Supplemental cash flow information related to leases is as follows (dollars in thousands):Nine Months EndedSeptember 30,20252024(unaudited)Cash paid for operating leases$14,415 $13,224 Lease assets obtained for new operating leases9,941 3,547 Lease obtained from Sage Acquisition As part of the Sage Acquisition, the Company acquired a lease for office space located in a multi-tenant building located in Cambridge, Massachusetts and classified this as an operating lease. Sages's office space lease term continues through February 28, 2030. See Note 3, Sage Acquisition, for the further discussion on the acquired lease asset and assumed lease liability.

14. Segment Reporting 

The Company operates in one operating segment and therefore has only one reportable segment. The Company derives revenue primarily from sales of its commercial products in the U.S.The Company's chief operating decision maker (CODM) is the chief executive officer. The Company manages the business activities on a consolidated basis. The CODM assesses performance of the Company, decides how to allocate resources based on net earnings (loss), which is reported in the condensed consolidated statement of earnings (loss) as